Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG) - Drug Trials For Money - Paid Clinical Trials

A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG)

A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG)
Conditions:   Diffuse Intrinsic Pontine Glioma;   Diffuse Midline Glioma, H3 K27M-Mutant
Interventions:   Drug: BXQ-350 – Part 1 Dose Escalation: Safety and Tolerance;   Drug: BXQ-350 – Part 2 BXQ-350 Tumor and Plasma Concentrations
Sponsors:   Bexion Pharmaceuticals, Inc.;   CTI Clinical Trial and Consulting Services
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

February 26, 2021 / by / in
Comments